ATE58294T1 - Pharmazeutische zusammensetzungen. - Google Patents
Pharmazeutische zusammensetzungen.Info
- Publication number
- ATE58294T1 ATE58294T1 AT87306297T AT87306297T ATE58294T1 AT E58294 T1 ATE58294 T1 AT E58294T1 AT 87306297 T AT87306297 T AT 87306297T AT 87306297 T AT87306297 T AT 87306297T AT E58294 T1 ATE58294 T1 AT E58294T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- aqueous solution
- taurultam
- taurolidine
- particularly suitable
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007864 aqueous solution Substances 0.000 abstract 2
- RJGYJMFQWGPBGM-UHFFFAOYSA-N 1,2,4-thiadiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCN1 RJGYJMFQWGPBGM-UHFFFAOYSA-N 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- AJKIRUJIDFJUKJ-UHFFFAOYSA-N taurolidine Chemical compound C1NS(=O)(=O)CCN1CN1CNS(=O)(=O)CC1 AJKIRUJIDFJUKJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960004267 taurolidine Drugs 0.000 abstract 1
- 229950007343 taurultam Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868617482A GB8617482D0 (en) | 1986-07-17 | 1986-07-17 | Pharmaceutical composition |
| EP87306297A EP0253662B1 (de) | 1986-07-17 | 1987-07-16 | Pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE58294T1 true ATE58294T1 (de) | 1990-11-15 |
Family
ID=10601226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87306297T ATE58294T1 (de) | 1986-07-17 | 1987-07-16 | Pharmazeutische zusammensetzungen. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0253662B1 (de) |
| JP (1) | JP2550356B2 (de) |
| KR (1) | KR950009096B1 (de) |
| AT (1) | ATE58294T1 (de) |
| AU (1) | AU604031B2 (de) |
| CA (1) | CA1287300C (de) |
| DE (1) | DE3766175D1 (de) |
| ES (1) | ES2026184T3 (de) |
| GB (1) | GB8617482D0 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614170B2 (en) * | 1988-08-26 | 1991-08-22 | Minnesota Mining And Manufacturing Company | A steam sensitive composition and a sterilization indicator composition containing the same |
| US8304390B2 (en) | 1997-07-31 | 2012-11-06 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method of treatment for preventing or reducing tumor growth in the liver of patient |
| US6479481B1 (en) | 1999-06-04 | 2002-11-12 | Ed. Geistlich Soehne Ag Fur Chemische Industrie | Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| US20030027818A1 (en) | 2001-04-03 | 2003-02-06 | Redmond H. Paul | Treatment of cancers |
| US6537969B1 (en) * | 1997-10-24 | 2003-03-25 | John P. Blass | Nutritional supplement for cerebral metabolic insufficiencies |
| FR2771928B1 (fr) * | 1997-12-05 | 2001-04-13 | Jean Noel Thorel | Composition comprenant des derives de taurine ; son utilisation comme agent conservateur d'un produit alimentaire, ou pharmaceutique, topique ou cosmetique |
| US6117868A (en) * | 1998-09-16 | 2000-09-12 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| US8030301B2 (en) | 1999-06-04 | 2011-10-04 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of cancers with methylol-containing compounds and at least one electrolyte |
| US6821968B2 (en) | 2001-09-26 | 2004-11-23 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Stable taurolidine electrolyte solutions |
| US7345039B2 (en) | 1999-06-04 | 2008-03-18 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| US7892530B2 (en) | 1999-06-04 | 2011-02-22 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of tumor metastases and cancer |
| CN100519525C (zh) | 1999-12-06 | 2009-07-29 | 葛兰素集团有限公司 | 芳香砜类及其医疗用途 |
| CA2393159C (en) | 1999-12-06 | 2010-04-20 | Paul Calabresi | Methods of treating tumors |
| CA2462564C (en) | 2001-10-01 | 2012-07-10 | Rhode Island Hospital | Methods of inhibiting metastases |
| EP3028705A1 (de) | 2006-09-07 | 2016-06-08 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Behandlung von knochenkrebs |
| ES2644870T3 (es) | 2012-06-18 | 2017-11-30 | Geistlich Pharma Ag | Derivados de oxatiazina como agentes antibacterianos y anticancerígenos |
| ES2907592T3 (es) | 2014-12-19 | 2022-04-25 | Geistlich Pharma Ag | Procesos para preparar compuestos de tipo oxatiazina |
| EP3429614B1 (de) | 2016-03-18 | 2023-05-03 | Geistlich Pharma AG | Verfahren zur behandlung von dreifach negativem brustkrebs |
| IL307990A (en) | 2021-04-29 | 2023-12-01 | Geistlich Pharma Ag | Antimicrobial and anticancer agents |
| WO2024028846A1 (en) | 2022-08-05 | 2024-02-08 | Geistlich Pharma Ag | Combination therapy for treating cancers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH600878A5 (de) * | 1975-04-28 | 1978-06-30 | Gaba Ag | |
| DE2731013C2 (de) * | 1977-07-08 | 1982-07-15 | Lentia Gmbh | Verfahren zur Herstellung einer wäßrigen Infusionslösung |
| US4296130A (en) * | 1979-08-30 | 1981-10-20 | Herschler R J | Methylsulfonylmethane and methods of use |
| JPS58116413A (ja) * | 1981-12-29 | 1983-07-11 | Nippon Kayaku Co Ltd | 静注用総合ビタミン剤 |
| GB8328111D0 (en) * | 1983-10-20 | 1983-11-23 | Geistlich Soehne Ag | Chemical compounds |
| JPS60246313A (ja) * | 1984-05-22 | 1985-12-06 | Yamanouchi Pharmaceut Co Ltd | 塩酸ニカルジピンの注射剤およびその製法 |
-
1986
- 1986-07-17 GB GB868617482A patent/GB8617482D0/en active Pending
-
1987
- 1987-07-16 DE DE8787306297T patent/DE3766175D1/de not_active Expired - Lifetime
- 1987-07-16 CA CA000542249A patent/CA1287300C/en not_active Expired - Lifetime
- 1987-07-16 AT AT87306297T patent/ATE58294T1/de active
- 1987-07-16 KR KR1019870007709A patent/KR950009096B1/ko not_active Expired - Fee Related
- 1987-07-16 EP EP87306297A patent/EP0253662B1/de not_active Expired - Lifetime
- 1987-07-16 ES ES198787306297T patent/ES2026184T3/es not_active Expired - Lifetime
- 1987-07-16 JP JP62176091A patent/JP2550356B2/ja not_active Expired - Fee Related
- 1987-07-17 AU AU75785/87A patent/AU604031B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0253662B1 (de) | 1990-11-14 |
| EP0253662A1 (de) | 1988-01-20 |
| ES2026184T3 (es) | 1992-04-16 |
| KR950009096B1 (ko) | 1995-08-14 |
| AU7578587A (en) | 1988-01-21 |
| GB8617482D0 (en) | 1986-08-28 |
| DE3766175D1 (de) | 1990-12-20 |
| KR880001283A (ko) | 1988-04-22 |
| JPS6372626A (ja) | 1988-04-02 |
| CA1287300C (en) | 1991-08-06 |
| AU604031B2 (en) | 1990-12-06 |
| JP2550356B2 (ja) | 1996-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE58294T1 (de) | Pharmazeutische zusammensetzungen. | |
| NO2002009I2 (no) | Tiotropium | |
| DK543587D0 (da) | Farmaceutisk praeparat stabiliseret mod oxidation | |
| DK543687A (da) | Stabiliseret farmaceutisk praeparat | |
| ATE72991T1 (de) | Nasale verabreichung von arzneimitteln. | |
| ATE169219T1 (de) | Behandlung von katarakt mit 15-keto- prostaglandinderivaten | |
| FI892498A0 (fi) | Aromatiska och heterocykliska karboxiamidderivat saosom antitumoera aemnen. | |
| DK463989D0 (da) | Farmaceutisk virksom kombination | |
| ES2093650T3 (es) | Una solucion farmaceutica que comprende derivados de fk506. | |
| ES2126636T3 (es) | Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria. | |
| DE69130586D1 (de) | Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten | |
| FI851261A0 (fi) | Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| UA27713C2 (uk) | Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі | |
| CA1271748C (en) | BENZAZEPINE DERIVATIVES | |
| ATE162717T1 (de) | Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten | |
| ATE104149T1 (de) | Dialysier- und spuelloesung zur intraperitonealen verarbreichung. | |
| ES2109244T3 (es) | Medicamentos que contienen compuestos de 3,7-diazabiciclo(3,3,1)nonano. | |
| DE68910165D1 (de) | Antihypertensive Sulfonanilide. | |
| KR920003972A (ko) | 프로스타시클린 화합물을 이용한 백내장 치료 | |
| SE8601963D0 (sv) | O-sulfated beta-lactam hydroxamic acids | |
| ATE71380T1 (de) | Aminoacylderivate von 4,9-dihydro-10h-pyrido(3,2b>thieno(3,2-e>(1,4>diazepinonen und 4,9-dihydro10h-pyrido(3,2-b>thieno(3,4-e>(1,4>diazepinonen ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ES2093051T3 (es) | Purinil- y pirimidil-tetrahidrofuranos. | |
| FI911285A0 (fi) | Antipsykotiska bicykliska 4-/4-(3-bensisotiazolyl)-1-piperazinyl/butylbryggimider. | |
| IT8519182A0 (it) | Derivati pirido-benzotiazinici adattivita' antimicrobica. | |
| FR2589734B1 (fr) | Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique |